DE602006016103D1 - Polymer-derivat von cytidin metabolit antagonist - Google Patents
Polymer-derivat von cytidin metabolit antagonistInfo
- Publication number
- DE602006016103D1 DE602006016103D1 DE602006016103T DE602006016103T DE602006016103D1 DE 602006016103 D1 DE602006016103 D1 DE 602006016103D1 DE 602006016103 T DE602006016103 T DE 602006016103T DE 602006016103 T DE602006016103 T DE 602006016103T DE 602006016103 D1 DE602006016103 D1 DE 602006016103D1
- Authority
- DE
- Germany
- Prior art keywords
- cytidine
- polymer derivative
- metabolite
- antagonist
- metabolite antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000005557 antagonist Substances 0.000 title 1
- UHDGCWIWMRVCDJ-XVFCMESISA-N cytidine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-XVFCMESISA-N 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/48—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0233—Polyamines derived from (poly)oxazolines, (poly)oxazines or having pendant acyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/3332—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing carboxamide group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/028—Polyamidoamines
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyethers (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005138249 | 2005-05-11 | ||
PCT/JP2006/308826 WO2006120914A1 (ja) | 2005-05-11 | 2006-04-27 | シチジン系代謝拮抗剤の高分子誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006016103D1 true DE602006016103D1 (de) | 2010-09-23 |
Family
ID=37396423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006016103T Active DE602006016103D1 (de) | 2005-05-11 | 2006-04-27 | Polymer-derivat von cytidin metabolit antagonist |
Country Status (13)
Country | Link |
---|---|
US (1) | US7700709B2 (de) |
EP (1) | EP1881020B1 (de) |
JP (1) | JP5000512B2 (de) |
KR (1) | KR101312417B1 (de) |
CN (1) | CN101218280B (de) |
AU (1) | AU2006245107B2 (de) |
BR (1) | BRPI0609095A2 (de) |
CA (1) | CA2606939C (de) |
DE (1) | DE602006016103D1 (de) |
ES (1) | ES2350258T3 (de) |
RU (1) | RU2404980C2 (de) |
TW (1) | TW200716151A (de) |
WO (1) | WO2006120914A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4745664B2 (ja) * | 2002-10-31 | 2011-08-10 | 日本化薬株式会社 | カンプトテシン類の高分子誘導体 |
CA2518964C (en) * | 2003-03-20 | 2011-09-13 | Nippon Kayaku Kabushiki Kaisha | Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
EP1792927B1 (de) | 2004-09-22 | 2013-03-06 | Nippon Kayaku Kabushiki Kaisha | Neues blockcopolymer, micellenzubereitung und antikrebsmittel, das diese als wirkbestandteil enthält |
WO2007111211A1 (ja) | 2006-03-28 | 2007-10-04 | Nippon Kayaku Kabushiki Kaisha | タキサン類の高分子結合体 |
KR20090009241A (ko) | 2006-05-18 | 2009-01-22 | 니폰 가야꾸 가부시끼가이샤 | 포도필로톡신류의 고분자 결합체 |
CN101489592A (zh) * | 2006-07-19 | 2009-07-22 | 日本化药株式会社 | 考布他汀的高分子量偶联物 |
EP2070971B1 (de) * | 2006-10-03 | 2016-06-22 | Nippon Kayaku Kabushiki Kaisha | Resorcinolderivatverbindung mit polymer |
EP2080779B1 (de) * | 2006-11-06 | 2016-05-18 | Nippon Kayaku Kabushiki Kaisha | Polymeres derivat eines nucleinsäuremetabolismus-antagonisten |
EP2089438B1 (de) * | 2006-11-07 | 2010-03-03 | DSM IP Assets B.V. | Carbamat, thiocarbamat oder carbamid mit einer biomolekularen gruppierung |
JP5548365B2 (ja) * | 2006-11-08 | 2014-07-16 | 日本化薬株式会社 | 核酸系代謝拮抗剤の高分子誘導体 |
US8703878B2 (en) | 2007-09-28 | 2014-04-22 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of steroids |
KR101589582B1 (ko) | 2008-03-18 | 2016-01-28 | 니폰 가야꾸 가부시끼가이샤 | 생리활성물질의 고분자량 결합체 |
WO2009136572A1 (ja) | 2008-05-08 | 2009-11-12 | 日本化薬株式会社 | 葉酸若しくは葉酸誘導体の高分子結合体 |
EP2431403B1 (de) | 2009-05-15 | 2016-09-28 | Nipponkayaku Kabushikikaisha | Polymerkonjugat aus einer bioaktiven substanz mit einer hydroxidgruppe |
US8840875B2 (en) | 2010-05-19 | 2014-09-23 | Paolo Ferruti | Anti-viral agents and compositions thereof |
IT1401360B1 (it) * | 2010-05-19 | 2013-07-18 | Lembo | Agenti anti-virali e relative composizioni |
CN103221054A (zh) * | 2010-11-17 | 2013-07-24 | 日本化药株式会社 | 新的胞苷类代谢拮抗剂的高分子衍生物 |
WO2012098557A1 (en) * | 2011-01-20 | 2012-07-26 | Institute Of Life Sciences | Pegylated gemcitabine derivative and process for preparing the same |
EP2754682B1 (de) | 2011-09-11 | 2017-06-07 | Nippon Kayaku Kabushiki Kaisha | Verfahren zur herstellung von blockcopolymer |
WO2014073447A1 (ja) | 2012-11-08 | 2014-05-15 | 日本化薬株式会社 | カンプトテシン類と抗癌効果増強剤の結合した高分子化合物及びその用途 |
JP2017160125A (ja) * | 2014-08-04 | 2017-09-14 | 日本化薬株式会社 | 核酸代謝拮抗剤が結合したポリアミノ酸誘導体。 |
CN107249589B (zh) | 2015-02-23 | 2021-06-08 | 日本化药株式会社 | 生理活性物质结合嵌段共聚物 |
WO2017086235A1 (ja) * | 2015-11-18 | 2017-05-26 | 日本化薬株式会社 | マクロライド系免疫抑制剤の高分子誘導体 |
WO2017119272A1 (ja) | 2016-01-08 | 2017-07-13 | 日本化薬株式会社 | マクロライド系免疫抑制剤の高分子誘導体 |
CN106117561B (zh) * | 2016-06-27 | 2020-03-13 | 中国科学院长春应用化学研究所 | 一种吉西他滨衍生物及其制备方法 |
WO2018008986A1 (ko) * | 2016-07-06 | 2018-01-11 | 주식회사 삼양바이오팜 | 수난용성 약물을 포함하는 고분자 미셀 제제의 시험관 내 방출시험 및 평가 방법 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0097307A3 (de) * | 1982-06-21 | 1985-01-09 | American Hoechst Corporation | Thermo-chemisch vernetztes Poly(p-methylstyrol) und Verfahren zu seiner Herstellung |
JP2517760B2 (ja) * | 1989-05-11 | 1996-07-24 | 新技術事業団 | 水溶性高分子化医薬製剤 |
JP3310000B2 (ja) | 1990-11-07 | 2002-07-29 | 靖久 桜井 | 水溶性高分子抗癌剤及び薬物担持用担体 |
JP3268913B2 (ja) * | 1992-10-27 | 2002-03-25 | 日本化薬株式会社 | 高分子担体 |
JPH0848766A (ja) * | 1994-05-30 | 1996-02-20 | Mitsui Toatsu Chem Inc | 重合体及びその製造方法 |
US5571889A (en) * | 1994-05-30 | 1996-11-05 | Mitsui Toatsu Chemicals, Inc. | Polymer containing monomer units of chemically modified polyaspartic acids or their salts and process for preparing the same |
JP2694923B2 (ja) | 1995-08-21 | 1997-12-24 | 科学技術振興事業団 | 水溶性高分子化医薬製剤 |
JPH11279083A (ja) | 1998-03-30 | 1999-10-12 | Nippon Kayaku Co Ltd | 可溶化剤 |
US6376470B1 (en) * | 1999-09-23 | 2002-04-23 | Enzon, Inc. | Polymer conjugates of ara-C and ara-C derivatives |
EP1362053B1 (de) * | 2001-02-20 | 2007-11-14 | Enzon, Inc. | Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate |
US20060233883A1 (en) * | 2003-03-26 | 2006-10-19 | Tsutomu Ishihara | Intravenous nanoparticles for targeting drug delivery and sustained drug release |
PT1675622T (pt) * | 2003-09-17 | 2017-09-19 | Nektar Therapeutics | Pró-fármacos de polímeros de múltiplos braços |
JP4723380B2 (ja) * | 2003-09-25 | 2011-07-13 | テルモ株式会社 | ポリエチレングリコール誘導体及びこれを膜構成成分とする薬物担体 |
SI1695991T1 (sl) * | 2003-12-10 | 2010-04-30 | Toudai Tlo Ltd | Koordinacijski kompleks diaminocikloheksan platine (II) z blok kopolimerom, ki vsebuje segment poli(karboksilne kisline) in antitumorni agens, ki jih vsebuje |
-
2006
- 2006-04-27 DE DE602006016103T patent/DE602006016103D1/de active Active
- 2006-04-27 CA CA2606939A patent/CA2606939C/en not_active Expired - Fee Related
- 2006-04-27 KR KR1020077025493A patent/KR101312417B1/ko not_active IP Right Cessation
- 2006-04-27 WO PCT/JP2006/308826 patent/WO2006120914A1/ja active Application Filing
- 2006-04-27 AU AU2006245107A patent/AU2006245107B2/en not_active Ceased
- 2006-04-27 RU RU2007145718/04A patent/RU2404980C2/ru not_active IP Right Cessation
- 2006-04-27 US US11/919,912 patent/US7700709B2/en not_active Expired - Fee Related
- 2006-04-27 CN CN2006800161666A patent/CN101218280B/zh not_active Expired - Fee Related
- 2006-04-27 JP JP2007528226A patent/JP5000512B2/ja not_active Expired - Fee Related
- 2006-04-27 BR BRPI0609095-8A patent/BRPI0609095A2/pt not_active IP Right Cessation
- 2006-04-27 ES ES06745754T patent/ES2350258T3/es active Active
- 2006-04-27 EP EP06745754A patent/EP1881020B1/de active Active
- 2006-05-09 TW TW095116441A patent/TW200716151A/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2404980C2 (ru) | 2010-11-27 |
JPWO2006120914A1 (ja) | 2008-12-18 |
AU2006245107A1 (en) | 2006-11-16 |
EP1881020B1 (de) | 2010-08-11 |
JP5000512B2 (ja) | 2012-08-15 |
BRPI0609095A2 (pt) | 2010-02-17 |
AU2006245107B2 (en) | 2011-02-10 |
CA2606939A1 (en) | 2006-11-16 |
RU2007145718A (ru) | 2009-06-20 |
ES2350258T3 (es) | 2011-01-20 |
WO2006120914A1 (ja) | 2006-11-16 |
US20090012252A1 (en) | 2009-01-08 |
CA2606939C (en) | 2013-09-03 |
KR101312417B1 (ko) | 2013-09-27 |
CN101218280A (zh) | 2008-07-09 |
EP1881020A1 (de) | 2008-01-23 |
KR20080013883A (ko) | 2008-02-13 |
EP1881020A4 (de) | 2009-09-02 |
TWI371284B (de) | 2012-09-01 |
US7700709B2 (en) | 2010-04-20 |
CN101218280B (zh) | 2012-06-27 |
TW200716151A (en) | 2007-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006016103D1 (de) | Polymer-derivat von cytidin metabolit antagonist | |
FR20C1027I2 (fr) | Derives de tiglien-3-one | |
DE602006007563D1 (de) | Agonisten | |
DE602006016566D1 (de) | Als antikoagulanzien verwendbare phenylglycinamid-derivate | |
DE112006002542A5 (de) | Elektroakustisches Bauelement | |
DE602006016573D1 (de) | Substituierte piperidine | |
BRPI0714764A2 (pt) | Derivados substituídos de sulfonamida | |
BRPI0716193A2 (pt) | Replicon derivado de potexvírus | |
ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
DK1856051T3 (da) | Amorft lercanidipinhydrochlorid | |
ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
DK1789800T3 (da) | Ileitis-diagnosetest | |
DE602007012260D1 (de) | Nitratester von piperidinen | |
DK2228656T3 (da) | Kvantificering af allergener | |
DE602006019103D1 (de) | Fluorsubstituierte 2-oxo-azepan-derivate | |
DE602006007885D1 (de) | Kleiderbügel | |
ATE524972T1 (de) | Poly-tlr-antagonist | |
ATE541837T1 (de) | Oxaphenanthren-derivate | |
DE602006009702D1 (de) | Dämpfer | |
DE502006002822D1 (de) | Ges | |
ATE477292T1 (de) | Polymer-derivat von cytidin metabolit antagonist | |
FI20065036L (fi) | Modifioitu trampoliinin pidinrakenne | |
FR2889236B1 (fr) | Charniere reglable | |
DE602006019209D1 (de) | Fluoroalkylpyrrolidin-derivate | |
UA12592S (uk) | Шафа-купе |